Sirolimus-eluting or everolimus-eluting stents for coronary artery disease: 5-year outcomes of the randomised BIOFLOW-IV trial.

ABSTRACT:

SUBMITTER: Slagboom T 

PROVIDER: S-EPMC9936249 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature